Nu-aryl-substituted bicyclic azacycles



United States Patent ABSTRACT OF THE DISCLOSURE l-aryl-quinazolines of the formulae Ilii Il a -N N 2 /63 2 9 Ph liq and Ph An II R; R4

Ph=a 1,2-phenylene R =aromatic radical R =aliphatic or aromatic radical R =O, S or an imino group R =arnino, etherified OH or SH orazacyclic arylidenemethyl An =an anion are anti-inflammants, dyes or intermediates.

This application is a continuation-in-part of application Ser'. No. 455,315, filed May 12, 1965, which in turn is a continuation-in-part of application Ser. No. 351,216, filed Mar. 11, 1964, now abandoned.

The present invention concerns and has for its object the provision of l-aryl-quinazoline compounds and methods for their preparation.

More particularly it relates to compounds having the formulae n. R1 i a i 2 and rn E A11 in which Ph stands for a 1,2-phenylene radical, R for a carbocyclic aryl group, R for an aliphatic radical or a carbocyclic aryl group, R for an imino group, R for an amino group, an aliphatically substituted hydroxy or mercapto group or an N-substituted azacyclic arylidenemethyl group in which the ring-nitrogen is part of an enamine grouping and An for the anion of an acid or the hydroxyl ion.

The 1,2-phenylene radical Ph may be unsubstituted or substituted by one or more than one of the same or different substituents attached to any of the positions available for substitution. Such substituents are, for example, lower alkyl, e.g. methyl, ethyl, n-propyl, or isopropyl, etherified hydroxy, such as lower alkoxy, e.g. methoxy, et'hoxy, n-propoxy, isopropoxy or n-butoxy, esterified hydroxy, such as halogeno, e.g. fluoro, chloro or bromo, etherified mercapto, such as lower alkylmercapto, e.g. methyl or ethylmercapto, trifiuoromethyl, nitro, amino, especially tertiary amino, such as di-lower alkylamino, e.g. dimethylamino or cliethylamino, alkylene- 3,385,855 Patented May 28, 1968 ice imino in which alkylene has from four to six carbon atoms, e.g. pyrrolidino or piperidino. Preferred 1,2-phenylene radicals Ph are 1,2-phenylene, (lower alkyl)-l,2-phenylene, (lower alkoxy) 1,2 phenylene, (halogeno)-l,2- phenylene, (lower alkylmercapto) 1,2 phenylene, (trifiuoromethyl) 1,2 phenylene, (nitro) 1,2 phenylene and (di-lower alkylamino)-l,2-phenylene.

Each of the carbocyclic aryl groups R, and R particularly stands for monocyclic carbocyclic aryl, i.e. phenyl or substituted phenyl, as well as for bicyclic carbocyclic aryl, i.e. a naphthyl or a substituted naphthyl. Said substituted aryl groups may contain one or more than one of the same or diiierent substituents attached to any position available for substitution, for example those mentioned for Ph. The aryl groups R and R therefore, are primarily phenyl, (lower alkyl)-phenyl, (lower alkoXy)-phenyl, (halogeno)-phenyl, (lower alkylmercapto)- phenyl, (trifluoromethyl)-phenyl, (nitro)-phenyl or (dilower alkyl-amino)-phenyl, as well as naphthyl, e.g. 1- naphthyl or Z-naphthyl, (lower alkyl)-naphthyl, (lower alkoxy)-naphthyl, (halogeno)-naphthyl, (lower alkylmercapto)-naphthyl, (trifluoromethyl)-naphthyl, (nitro)- naphthyl or (di-lower alkyl-amino)-naphthyl.

An aliphatic radical R represents especially lower alkyl, e.g. methyl, ethyl, n-propyl, isopropyl or n-butyl, as well as lower alkenyl, e.g. allyl, cycloalkyl or cycloalkyl-lower alkyl having from three to eight, especially from five to seven, ring-carbon atoms, e.g. cyclopropyl, cyclopentyl, cyclohexyl, eycloheptyl or cyclooctyl; cyclopropylmethyl, cyclopentylmethyl, 2 cyclopentylethyl, cyclohexylmethyl, l-cyclohexylethyl or cycloheptylmethyl, monocyclic car-bocyclic aryl-lower alkyl, e.g. benzyl, l-phenylethyl or 2-phenylethyl. The above radicals may contain additional substituents, especially in the aromatic portion, such as those mentioned for Ph, as well as OX0 or thiono, or the aliphatic radicals may be interrupted by hetero atoms, preferably by one oxygen, sulfur and/or nitrogen atom. Such radicals are, for example, lower alkoXy-lower alkyl groups, such as methoxymethyl, ethoxymethyl, n-propoxymethyl, 1- or Z-methoxyethoxy or i-propoxy-ethyl, 1-, 2- or 3-methoxy-, ethoxy or npropoxy-propyl or 4-tert. butoxy-butyl, the corresponding phenoxy-lower alkyl and lower alkylmercapto-lower alkyl groups, monoor di-lower alkylamino-lower alkyl, alkyleneimino-lower alkyl or aza-, oxaor thia-alkyleneimino-lower alkyl or N-phenyl-aza-alkyleneimino-lower alkyl groups with 4 to 6 ring-carbon atoms and in which latter the hetero-atom is preferably separated from the ring-nitrogen atom by at least two carbon atoms, such as 2-methylarnino-, Z-dimethylaminoor 2-diethylaminoethyl, 3-dimethylaminoor 3-diethylamino-propyl, 2-pyrrolidino-ethyl, 3-piperidino-propyl, 2-piperazino-ethyl, 2- (4-methyl-piperazino)-ethyl, 3-(4-ethyl-piperazino)- propyl, 2-(4-phenyl-piperazino)-ethyl, 2-morph0lino-ethyl or 3-thiamorpho1ino-propyl.

The imino group R can be unsubstituted, but preferably is substituted by the aliphatic or aromatic radicals mentioned for R furthermore by hydroXy, lower alkoxy, such as that mentioned above, hydroXy-lower alkyl, such as 2-hydroxy ethyl, 2- or 3-hydroXy-propyl or 2,3-dihydroxy-propyl, carboXy-lower alkyl or carbo-lower alkoxylower alkyl, such as carboXy-methyl, 2-carboxy-ethyl, carbethoxymethyl or 3-carbomethoxy-propyl, or heterocyclic aryl, such as pyridyl, e.g. 2-, 3- or 4-pyridy1, thienyl, e.g. 2-thienyl or furyl e.g. S-furyl.

An amino group R may also be unsubstituted or substituted as shown for R It preferably contains besides hydrogen or lower alkyl one of the aliphatic or aromatic radicals mentioned as substituents of the imino group R An aliphatically substituted hydroxyor mercapto group R is especially lower alkoxy or lower alkylmercapto, but may also be a hydroxy or mcrcapto group containing those aliphatic radicals shown for R The azacyclic arylidenemethyl group R, has, for example, the formula in which R is above all hydrogen, but may also stand for one of the radicals listed for R and Q stands for an N-substituted mono or polycyclic, especially bicyclic, azacyclic arylidene radical, such as a l-substituted 2- or 4-pyridylidene or 2- or 4-quinolylidene radical, a 2-substituted l-isoquinolylidene radical, a 3-substituted 2-thiazolylidene, Z-benzthiazolylidene, 2-oxazolylidene or 2- benzoxazolylidene radical or a 1,3,3-tri-substituted 2-indolylidene radical in which the ring-nitrogen is part of an enarnine grouping. In the above azacyclic radicals representing Q, the substituent of the ring-nitrogen atom is above all an aliphatic radical, e.g. lower alkyl, as well as lower alkyl substituted by any of the previously mentioned substituents, or an araliphatic radical, such as monocyclic carbocyclic aryl-loweralkyl, as Well as an aryl radical, for example, one of those radicals representing R Apart from the group substituting the ring-nitrogen atom, the azacyclic ring is unsubstituted or may have one or more than one additional substituent such as lower alkyl, etherified hydroxy, e.g. lower alkoxy, esterified hydroxy, e.g. halogeno, etherified mercapto, e.g. lower alkylmercapto, trifiuoromethyl, nitro and tertiary amino, e.g. di-lower alkylamino, of the meaning given above.

An ion An is above all the anion of an acid, primarily the anion of an inorganic acid, especially of a hydrohalic acid, e.g. hydrochloric, hydrobromic or hydriodic acid or of sulfuric, thiocyanic or perchloric acid as well as the anion of an organic acid, such as a carboxylic acid or sulfouic acid, e.g. acetic, oxalic, maleic, hydroxymaleic, fumaric, malic, tartaric, citric, benzoic or salicylic acid, or more especially of methane sulfonic, ethane sulfonic, 2-hydroxy-ethane sulfonic, 1,2-ethane disulfonic, benzene sulfonic, p-toluene sulfonic or Z-naphthalene sulfonic, acid, or of a monobasic organic sulfuric acid, such as a lower alkyl-sulfuric acid, e.g. methyl or ethyl-sulfuric acid, as well as the anion of an acidic organic nitro compound, e.g. picric, picrolonic or fiavianic acid, or of a metal complex acid, e.g. phosphotungstic, phosphomolybdic, chloroplatinic or Reinecke acid. In the event that the compounds of this invention are used for pharmaceutical purposes, the anion A11 is that of a pharmaceutically acceptable acid.

The compounds of this invention have valuable pharmacological properties. For example, they exhibit antimicrobial effects, such as against gram-positive bacteria, e.g. Diplococcus pneunzoniae, Staphylococcus aureus and the like, against gram-negative bacteria, e.g. Escherichia coli, Pseudomonas aeruginosa, Salmonella choleraesuis and the like, against acid-fast bacteria, e.g. Microbacteriwn tuberculosis and the like, against fungi, e.g. Candida albicans, Cryptococcus neoformans, Histoplasma capsulatum, Triclzophyton menragrophytes and the like, as well as against protozoa, e.g. T richomonas vnginalis and the like. They are, therefore, useful as antimicrobial agents, either topically or systemically, against bacterial, fungal or protozoal infections. They also show activities against helminths, such as Nippostrongylus muris and the like, and are, therefore, useful as anthelmintic agents. Furthermore they exhibit anti-inflammatory effects, especially those compounds of Formulae I and II in which R, and R stand for an imino or amino group respectively. This can be demonstrated, for example, in the granuloma pouch test or the earragcenin rat paw test, at oral doses between about 5 and 50 mg./kg./day, preferably between about and 25 mg./kg./day. They are, therefore useful as anti-inflammatory agents, preferably for oral application, in place of corticosteroids, such as cortisone or hy- 4 drocortisone, in the treatment of tissue inflammations, such as arthritic infiammations and similar conditions.

The compounds of Formula II in which R represents an N-substituted azacyclic arylidenemethyl group, are eyanine dyes containing at least two auxochromic nitrogen atoms, one being of tertiary, the other of quaternary characteristics. One of these nitrogen atoms is the ring member of one hetcrocyclic ringsystem, the secondof another heterocyclic ring system, and both are linked with each other through a conjugated chain of double bonds. These dyes are also excellent sensitizers of photographic emulsions without causing excessive fog or residual dye stain.

Particularly useful are compounds of the formulae R5 R5 i g r112 It and Pl 1\[I A11 9 C/ I l-R; 1'1,

(III) (IV) in which Ph stands for 1,2-phenylene, (lower alkyl)-l,2- phenylene, (lower alkoxy)-1,2-phenylene, (halogeno)-l,2- phenylene, (lower alkylmercapto)-l,2-phenylene or (nitro)-l,2-phenylene, R for phenyl, (lower alkyl)-phenyl, (lower alkoxy)-phenyl, (halogeno)-phenyl, (lower alkylmercapto)-phenyl or (nitro)-phenyl, R for lower alkyl, phenyl, (lower alkyl)-phenyl, (lower alkoxy)-phenyl, (halogeno)-phenyl, (lower alkylmercapto)-pheny1 or (nitro)-phenyl, R for hydrogen, lower alkyl, amino'lower alkyl, monoor di-lower alkyla-mino-lower alkyl, alkyleneimino-lower alkyl in which alkylene has from four to six carbon atoms, aza-, oxaor thiaalkyleneimino-lower alkyl in which the heteroatom is separated from the ringnitrogcn by at least two carbon atoms and the ring has from four to six carbon atoms, carboxy-lower alkyl or carbo-lower alkoxy-lower alkyl, R for lower alkylmercapto, di-lower alkylamino or an at most bicyclic N-lower alkyl-azacyclic, -thiazacyclic or -oxazacyclic arylidenemethyl group in which the ring-nitrogen is part of an enamine grouping and A11 for a halogenide ion.

Especially valuable are those compounds of the Formulae III and IV in which Ph stands for 1,2-phenylene, R for phenyl, (lower alkyl)-phenyl, (lower alkoxy)- phenyl or (halogeno)-phenyl, R for lower alkyl, phenyl, (lower alkyl)-phenyl, (lower alkoxy)-phenyl or (halogeno)-phenyl, R for lower alkyl, R for lower alkylmercapto, di-lower alkylamino, l-lower alkyl-2-quinolylidenemethyl, 3-lower alkyl-2-benzthiazolylidenemethyl or 3-lower alkyl-2-benzoxazolylidenemethyl and An for a halogenide ion.

The compounds of this invention are prepared according to known methods. For example, the process for their preparation comprises the method, wherein (a) A 1-aryl-4-oxo or thiono-quinazoline, more particular a compound of the formula in which X stands for an 0x0 or thiono group, is reacted with ammonia, a primary amine or a reactive ester of an aliphatic alcohol, or

(b) A 1-aryl-S,6,7,8-tetrahydro-quinazoline, more particularly a compound of the formulae is dehydrogenated and, if desired, a reaction product obtained from the reactive ester, is treated with ammonia, an amine containing at least one hydrogen atom or a quaternary N-substituted azacyclic arylmethyl compound of which the methyl group contains at least two hydrogen atoms and the ring-nitrogen is capable of forming an enamine grouping and/ or a product obtained, containing a free or mono-substituted imino or amino group respectively, is reacted with a reactive ester of an aliphatic or aromatic alcohol and/ or in a quaternary compound obtained, the anion is converted into the hydroxyl ion or another anion.

A reactive ester of the aliphatic alcohol, for example, is an ester with an inorganic acid, particularly a hydro halic acid, e.g. hydrochloric, hydrobromic or hydriodic acid, as well as sulfuric acid, or with a strong organic sulfonic acid, e. g. methane sulfonic, Z-hydroxyethane sulfonic or p-toluene sulfonic acid. Preferred reactive esters of the aliphatic alcohol are those with hydrohalic acids having a molecular weight greater than 20.

The quaternary arylmethyl compound more particularly is that of the formula [Q -CH -R An in which Q stands for a quaternary N-substituted azacyclic aryl radical capable of furnishing the group Q. Q more particularly represents a quaternary 2- or 4-pyridyl, 2- or 4-quinolyl, l-isoquino-lyl, Z-thiazolyl, Z-benzothiazolyl, 2- oxazolyl, Z-benzoxazolyl or 3,3-disubstituted 2-indolenyl radical in which the group attached to the quaternary nitrogen atom is above all lower alkyl, whereas R has the previously given meaning, but represents primarily hydrogen, and An is above all a halogenide ion.

The above reactions are carried out in the usual manner by combining the reactants of the absence or advantageously in the presence of a diluent, preferably such that is inert to the reactants and is a solvent thereof, in the presence or absence of a catalyst, condensing or neutralizing agent, while cooling at room temperature or advantageously at elevated temperatures, under atmospheric or super-atmospheric pressure and/ or in the atmosphere of an inert gas, e.g., nitrogen.

A neutralizing agent is preferably used in the reaction with the reactive ester and quaternary arylmethyl compounds. Such agent is, for example, an alkali or alkaline earth metal carbonate or lower alkoxide, or more especial- 1y, an organic base such as pyridine or collidine, but particularly an aliphatic tertiary amine, such as a tri-lower alkylamine, a tetra-lower alkyl-alkylenediamine, an N- lower alkylalkyleneimine, an N-lower alkyl-morpholine or a mixture thereof, such as a mixture of pyridine and triethylamine.

The dehydrogenation according to method (b) is carried out in the usual manner either catalytically, e.g. With the use of palladium, platinum and nickel catalysts, chromium oxide and chromia-alumina catalysts, or by means of dehydrogenation agents, such as sulfur, selenium, oxide, isoamyl disulfide and chloranil.

In a resulting quaternary compound the anion may be converted into another anion according to known methods. Thus, the anion of an acid may be replaced by the hydroxyl ion, for example, by reacting a resulting quaternary halide with silver oxide, or a quaternary sulfate with barium hydroxide, by treating a quarternary salt with an anion exchange preparation or by electrodialysis. From any resulting quaternary hydroxide, there may be obtained quaternary salts by reacting the quaternary base with an acid, for example, one of those mentioned hereinbefore. A resulting quaternary salt may also be converted directly into another quaternary salt without the formation of an intermediate quaternary hydroxide. For example, a quaternary iodide may be reacted with freshly prepared silver chloride or with hydrochloric acid in anhydrous methanol to yield the quaternary ammonium chloride; a quaternary salt may also be converted into another quaternary salt by treatment with an anion exchange preparation. Quarternary ammonium compounds may also crystallize as the hydrates.

The starting material mentioned under item (b) is disclosed in copending application Ser. No. 488,241, filed concurrently with the present application. That of Formula V, in which X stands for thiono, as well as the acid addition salts thereof, for example, those with the previously mentioned acids, is new and is intended to be included within the scope of this invention. It is prepared, for example, from the corresponding 4-oxo-compound by treatment with phosphorus pentasulfide in the presence of a high-boiling solvent, cg. xylene.

The starting material of Formula V, in which X stands for 0x0 can be obtained according to methods known per se, for example, by

(a) Reacting a compound of the formula in which Hal stands for a halogen atom, with ammonia or an ammonia-furnishing reagent, or

(b) Subjecting a compound having one of the formulae R1 R1 0 It Ph C R. Pr t R.

ONHz i c oNm (VII) (VII to an elevated temperature.

The acid halide of the Formula VI can be obtained by treating the acid R --NHPh-COOH with a reactive functional derivative of the acid R COOH, such as a halide, e.g. the chloride or the anhydride thereof, and treating the acid obtained with a thionyl halide, e.g. thio nyl chloride, at phosphoric acid halide, e.g. phosphorus tribromide, phosphorus pentachloride or phosphorus oxychloride.

The acid amide of the Formula VII, which is formed in reaction (a) as an intermediate, can be obtained by reaction of the acid amide R NH-PhCONH with a re active functional derivative of the acid R -COOH.

The acid amide of the Formula VIII may be obtained by reaction of the acid amide HOPhCONH with the imidoyl halide .lIal

wherein R preferably is a carbocyclic aryl group, in the presence of an alkali metal lower alkoxide.

The present invention also comprises any modification of the process, wherein a compound obtainable as an intermediate at any stage thereof is used as starting material and any remaining steps are carried out, or the process is discontinued at any stage thereof, or in which the starting materials are formed under the reaction conditions or are used in the form of their salts.

Mainly those starting materials should be used in the present process that lead to the formation of those cornpounds indicated above as being especially valuable.

The compounds of this invention are useful in the form of compositions for enteral, parenteral or topical administration, which contain a pharmacologically effective amount of the compounds of this invention in admixture with a pharmaceutically acceptable, organic or inorganic, solid or liquid carrier, which usually represents the major portion of the pharmaceutical composition. For making up the latter, there are employed carrier materials suitable for the preparation of pharmaceutical compositions, such as water, gelatine, sugars, e.g. lactose, glucose or sucrose, starches, e.g. corn starch, wheat starch or rice starch, stearic acid or salts thereof, e.g. calcium or magnesium stearate, talc, vegetable oils, alcohol, e.g. ethanol, benzyl alcohol or cetyl alcohol, petrolatum, gums, acacia, propylene glycol, polyalkylene glycols or any other known carrier for pharmaceutical compositions. The pharmaceutical preparations may be in solid form, e.g. capsules, tablets or drages, in liquid form, e.g. solutions or suspensions, or in the form of emulsions, e.g. salves or creams. If desired, they may contain auxiliary substances,

such as preserving, stabilizing, wetting, emulsifying, or coloring agents, salts for varying the osmotic pressure or buffers. The above preparations are prepared according to standard methods used for the manufacture of pharmaceutically acceptable compositions, which, if desired, also contain, in combination, other physiologically useful substances.

In order to be used as cyanine dyes in the sensitization of photographic silver halide emulsions, the arylidenemethyl compounds of this invention are dispersed in the emulsions, such as gelatino-silver halide emulsions, e.g. gelatino-silver bromide, gelatino-silver bromoiodide, gelatino-silver chloride or gelatino-silver chloroiodide. The methods of incorporating these dyes in emulsions are conventional and are described in the art.

The following examples are intended to illustrate the invention and are not to be construed as being limitations thereon. Temperatures are given in degrees Centigrade and all parts wherever given are parts by weight.

Example 1 A mixture of 8.75 g. of 1-(4-fluoro-phenyl)-2-phenyl- 1,4-dihydro-quinazoline-4-thione and ml. of methyl iodide is refluxed for 1% hours. The solid l-(4-fiuorophenyl) 4 methyl mercapto 2 phenyl quinazolinium iodide of the formula is filtered off, yield: 11.0 g., and recrystallized from acetone, M.P. 270-290 (with decomposition).

The starting material used in the above procedure is prepared as follows: To a mixture of 33.3 g. of 4-fluoroaniline in 100 ml. of pyridine is added slowly 42.1 g. of benzoyl chloride while cooling. The reaction mixture is poured into 600 ml. of water and the benzoyl N-(4-fluorophenyl)-amide is filtered off, washed with water and recrystallized from ethanol, M.P. 183-187".

A mixture of 46.0 g. of benzoyl N-(4-fiuoro-phenyl)- amide and 100 ml. of thionyl chloride is refluxed for three hours. The excess of thionyl chloride is distilled off, and the desired N-(4-fiuoro-phenyl)-benzimidoyl chloride is purified by distillation and collected at 180/20 mm.

To a cold solution of 1.35 g. of sodium methoxide in 50 ml. of ethanol is added in rapid succession 4.56 g. of methyl salicylate and a solution of 4.66 g. of N-(4-fluorophenyl)-benzimidoyl chloride in 25 ml. of diethyl ether. The reaction mixture is allowed to stand at room temperature for thirty minutes and is then evaporated. The residue is Washed with water, filtered off and recrystallized from ethanol to yield the carbomethoxy-phenyl N-(4-fiuorophenyl)-benzimidoate, which melts at 126-130.

A total of 85.0 g. of 2-carbomethoxy-phenyl N-(4- fluoro-phenyl)-benzimidoate is heated at 275 for ten minutes. After cooling, diethyl ether is added, and the methyl N-benzoyl-N-(4-fluoro-phenyl)-anthranilate is filtered oiT and recrystallized from methanol, M.P. 116.

To 34.9 g. of methyl N-benzoyl-N-(4-fluoro-phenyl)- anthranilate in 200 ml. of ethanol is added 110 ml. of water, and 110 ml. of a solution consisting of 5.4 g. of sodium methoxide, 100 ml. of ethanol and 20 ml. of water. The reaction mixture is refluxed for 1%. hours and then concentrated. The aqueous mixture is acidified with concentrated hydrochloric acid and is then extracted with methylene chloride. The organic solvent is evaporated, the residue is extracted with an aqueous solution of sodium hydrogen carbonate, and the aqueous extract is acidified with hydrochloric acid. The precipitate is filtered oif, and dissolved in methylene chloride; the organic solution is dried over sodium sulfate and diluted with hexane. The desired N-benzoyl-N-(4-fluoro-pheny])-anthranilic acid precipitates and is recrystallized from diethyl ether, M.P.176-178.

A mixture of 20.0 g. of N-benzoyl-N-(4-fluoro-phenyl)- anthranilic acid and 100 ml. of phosphorus oxychloride is refluxed for nineteen hours. The excess of phosphorus oxychloride is distilled and the residue is taken up into approximately 200 ml. of methylene chloride. The resulting solution of the N-benzoyl-N-(4-fiuoro-phenyl)- anthranilic acid chloride is treated for one hour with gaseous ammonia until the reaction mixture has become basic. It is then washed with Water, dried over sodium sulfate and concentrated. 8.3 g. of a white precipitate is filtered off, and is combined with 6.0 g. of additional material obtained by diluting the mother liquors with hexane. The desired 1-(4-fiu0ro-phenyl)-2-phenyl-3,4-dihydro-quinazolin-4-one melts at 289-290" after recrystallization from acetone and hexane.

A mixture of 10.5 g. of l-(4-fluoro-phenyl)-2-phenyl- 1,4-dihydro-quinazolin-4-one and 8.9 g. of phosphorus pentasulfide in ml. of xylene is refluxed for two hours while stirring. After cooling, 60 ml. of a ten percent aqueous solution of sodium hydroxide is added; the precipitate is filtered ofii, Washed with hot ethanol and recrystallized from acetone, using a charcoal preparation for clearing the solution. The desired 1-(4-fluoro-phenyl)- Z-phenyl-l,4-dihydro-quinazolin-4-thione of the formula melts at 293-296; yield: 5.7 g.

Example 2 A mixture of 8.5 g. of 1,Z-diphenyl-1,4-dihy-dro-quinaZolin-4-thione and 15 ml. of methyl iodide is refluxed 9 for two hours. The desired 1,2-diphenyl-4-methylmercaptoquinazolinium iodide of the formula S-CHa is filtered off and recrystallized from acetone.

The starting maten'al used in the above procedure is prepared as follows: To a cold solution of 1.35 g. of sodium methoxide in 25 ml. of absolute ethanol is added rapidly a solution of 4.1 g. of salicylic acid amide in 25 ml. of absolute ethanol and then 4.3 g. of Nphenylbenzimidoyl chloride in 25 ml. of anhydrous diethyl ether. The reaction mixture is allowed to stand at room temperature for 1 /2 hours, and is then concentrated to a small volume, and diluted with water. Upon cooling and scratching, the yellow oil solidifies, and is filtered off and dissolved in diethylether; the organic solution is dried over sodium sulfate and evaporated. The resulting 2- c-arbamyl-phenyl N-phenyl-benzimidoate is crystallized from a mixture of diethyl ether and pentane, and melts at 136138 from a mixture of acetone and hexane.

A mixture of 2.0 g. of 2-carbamyl-phenyl-N-phenylbenzimidoate in 200 ml. of diphenyl ether is refluxed for two hours in a Soxhlet apparatus containing anhydrous sodium sulfate in the thirnble. The solution is then concentrated to dryness under reduced pressure; upon adding diethyl ether to the residue, the 1,2-diphenyl-1,4-dihydroquinazolinl-one is obtained, M.P. 265273.

The above 1,2-diphenyl-1,4-dihydro-quinazolin-4-one is also prepared as follows: To a suspension of 17.4 g. of N-phenyl-anthrauilic acid in 250 ml. of pentane is added in portions 16.8 g. of phosphorus oxychloride. After standing at room temperature for one hour and filtering, the filtrate is concentrated under reduced pressure, decolorized with a charcoal preparation and frozen in a mixture of solid carbon dioxide and acetone. The solid N-phenyl-anthranilic acid chloride is filtered off and rapidly added to 250 ml. of a cold concentrated solution of ammonia in water. The reaction mixture is allowed to stand at room temperature for three hours; the N-pheuylanthranilic acid amide is filtered 01f, crystallized from diethyl ether and recrystallized from the same solvent, M.P. 129-13.1.

To a solution of 0.212 g. of N-phenyl-anthranilic acid amide in 2 ml. of pyridine is added 0.14 g. of benzoyl chloride; the reaction mixture is allowed to stand for twenty minutes at room temperature and is then poured into water. The oily material is extracted with methylene chloride, the organic solution is filtered through anhydrous sodium sulfate and is evaporated to dryness. The residue solidifies in diethyl ether and is filtered off to yield the N-benzoyl-N-phenyl-anthranilic acid amide, M.P. 235237, after two recrystallizations from ethanol.

Upon heating to approximately 300 the N-berzoyl- N-phenyl anthranilic acid amide melts; the product is cooled and recrystallized from ethanol to yield the desired 1,2-diphenyl-l,4-dihydro-quinazolin-4-one.

The latter is also obtained as follows: A mixture of 13.0 g. of N-benzoyl-N-phenyl-anthranilic acid and 325 m1. of phosphorus oxychloride is refluxed for nineteen hours. The excess of phosphorus oxychloride is evaporated, and the resulting N-benzoyl-N-phenyl-anthranilic acid chloride is dissolved in methylene chloride. Gaseous ammonia is bubbled through the solution for fifteen minutes, which is then allowed to stand at room temperature for one hour. After washing it with water, the organic solution is dried over sodium sulfate, decolorized with a charcoal preparation and concentrated. Upon dilution with hexane, a precipitate is formed, consisting of N-benzoyl-N-phenyl-anthranilic acid amide and 1,2-diphenyl-1,4-dihydro-quinazolin-4-one. The latter is obtained by heating the mixture to 300 and cooling it to room temperature. The desired 1,2-diphenyl-1,4-dihydroquinazolinA-one melts at 273275.5 after recrystallization from ethanol.

A mixture of 3.5 g. of -1,2-diphenyl-1,4-dihyclroquinazolin-4-one and 3.13 g. of phosphorus pentasulfide in 35 ml. of xylene is refluxed for two hours while stirring. After cooling, '21 ml. of a 1 0 percent aqueous solution of sodium hydroxide is added, and the reaction mixture is stirred for fifteen minutes. The solid material is filtered otf, washed with hot ethanol and recrystallized from N,N-dirnethylformamide to yield the desired 1,2-diphenyl- 1,4-dihydro-quinazolin-4-thione of the formula Example 3 A mixture of 4.3 g. of Z-methyl-1-phenyl-quinazolin-4- thione and 1 0 ml. of methyl iodide, when reacted as described in Example 1, yields the 2-methyl-4-methylmercapto-l-phenyl-quinazolinium iodide of the formula I N c on I S-CHa which is purified by recrystallization from acetone.

The starting material used in the above procedure is prepared as follows: A mixture of 10.6 g. of N-phenylanthranilic acid amide and 5.1 g. of acetic acid anhydride is refluxed for seventeen hours. The acetic acid anhydride is evaporated under reduced pressure, and the residue is diluted with acetone. Upon seeding with an original sample, the Z-methyl-l-phenyl-l,4-dihydro-quinazoliur4-one precipitates and is filtered off; it melts at 231-233 after recrystallization from acetone.

Upon treatment of 2.0 g. of Z-methyl-l-phenyl-1,4-dihydro-quinazolin-4one with 1.8 g. of phosphorus pentasulfide in the presence of xylene according to the procedure described in Example 2, the 2-methyl-1-phenyl-l,4- dihydro-quinazoliu-4-thione of the formula is formed.

1 1 Example 4 A mixture of 2.5 g. of 1-(4-methoxy-phenyl)-2-phenyl- 1,4-dihydro-quinazolin-4-thione and 5 ml. of methyl iodide, when reacted as described in Example 1, yields 1 2 Example 5 1,4-dihydro-quinazolin-i-thione starting Quaternizing reagent 4-substituted mercaptoquinazolinium products material 2-methyl-1-phenyl-1,4-dihydro-qui11az0liu-4- Methyl iodide Q-mgtlayl-i-methylmereapto-1-phenyl-quinazolinium thione. i0 i e. 2-etl1y1-1-(4-methyl-phenyD-l(4-dihydro-quinazo1in-4- do 2-ethyl-4-rnethylmereapto-1-(4-methyl-phenyD-quinathione. zolinium iodide. Z-benzyl-1-(S-trifiuoromethvlphenyD-l,4-dihydrod0 Z-benzyl-4-methylrnercapto-1-(3-triIluoromethyl-phenyD- quinazolin-4-thione.

quinazolinium iodide.

1,2}?iphenyl-fi-methoxy-l,4-dihydr0quinaz0lin-4- Ethyl iodide 4-etl(11y(l1mercapto-l,2-diphenyl-(s-methoxyquinazolinium t ione. io i e. 1,z-dilphenyl-o-methyl,14-dihydroquinazolin- Methyl iodide ,ii-ddiplhenyl-fi-methy1-4-methylmercapto-quinazoliniun1 4-t ione. o i e. (rehloro-l,2-diphenyl-l,4dihydro-quinoz0lin-4-thi0ne .d0 dehogo-l,Z-dipl1enyl-4-methylmercapto-quinazolinium 10 l e. 1-(3,4-dichlorophenyl)-2-(i-mothyl-phenyl)-1,4-dihydro- .d0 1-(3,4-diehloro-pheny1)-4-methy1mercapto-2-(4-methylquiiiazoliti-4-thioiie. phenyl-q uinazolinium iodide. 1-(4-bromo-phenyl)-2-isopropyl-l,4-dihydro-qumazolin- Benzyl bromide 4-bei1zylmercapto-l-(4-bronio-phcnyl)-2-isopropyl- 4-thiono. quinazolinium bromide (converted into the cor responding iodide by treatment with an excess oi sodium iodide. 2-(3-nitro-phenyl)-1-phenyl-l,4-dihydro-qumozo11u-4- Methyl iodide 4-methylmercapto-L (3-nitro-pheny1)-1-pheny1- thione. quinazoliniuni iodide. 2-(4-bromo-phenyl)-1-phenyl-1,4-dihydro-quinazoliiwi- .do 2-(4-bromo-phenyl)-4-methylmercapto-l-phenylthione. I quinazoliniuin iodide. lot-mothyl-phenyl)-1-phenyl-l,4-d1hydr0-qumazolu1-4- .do 4-methylmercapto-2-(4-methyl-pheny1)-1-plieny1- thione. quinazolinium iodide. 2-(4-methoxy-pheuyl)-l-(2-napl1tl1y1)-1,4-d1hydr0- d0 2-(4-methoxy-phenyl)-4-metl1ylmercapto-1-(2-naphthyl)- quinazolin-i-thione. quinazolinium iodide. 2-(4-:nethyhnereaptophenyl)-l-phenyl-1,4-d1l1ydro- Ethyl iodide 4-ethylmcrcapto-2-(4-methylmercapto-phenyl) -1-phenylquinozolin-i-thione. v quinazolinium iodide. 1(4-ehloro-phenyl)-2-phenyl-1,4-dihydro-qu1nazohn-i- Methyl iodide 1-(4-chloro-plrenyl)4-methylmereepto-2plieny1- thione.

quinazolinium iodide.

the 1-(4-metl1oxy-phenyl) 4 methylmercapto-Z-phenylquinazolinium iodide of the formula (i)ClIa which is recrystallized from acetone.

The starting material used in the above procedure is prepared as described in Example 1, i.e. by reacting methyl salicylate with N-( l-methoxy-phenyl)-benzimidoyl chloride in the presence of sodium methoxide, heating the resulting Z-carbomethoxy-phenyl N-(4-methoxypheny1)-benzimidoate (M.P. 115-117, after recrystallization from ethanol) at 275, hydrolyzing the methyl N benzoyl N-(4-methoxy-phenyl)-anthranilate (M.P. 151-153", after recrystallization from a mixture of ace tone and hexane) with sodium hydroxide in aqueous ethanol, converting the N-benzoyl-N-(4-methoxy-phenyl)-anthranilic acid (M.P. 184-187, after recrystallization from a mixture of acetone and hexane) into its amide, by treating the acid chloride with ammonia, heating the N benzoyl N-(4-methoxy-phenyl)-anthranilic acid amide, contaminated with 1-(4-methoxy-phenyl)-2- phenyl-1,4-dihydro-quinazolin-4-one, to 300, and reacting the l-(4-methoxy-phenyl)-2-phenyl-1,4-dihydroquinazolin-4-one (M.P. 240-243", after recrystallization from ethanol) with phosphorus pentasulfide.

Example 6 i HC:

which melts at 305-306.5 after recrystallization from ethanol.

Example 7 Other 4-azaarylidenemethyl-l-aryl-quinazolinium compounds prepared according to the previously described and illustrated procedure by selecting the appropriate starting materials, are, for example i 4-substituted mercepto quinazolinium compounds 1,2-diphenyl--methylmercaptoquinazolinium iodide.

1-(4-chloro-pheny1)-4-methylmercapto-Z-phenylquinazolinium iodide.

2-methylA-methylmercaptod-phenylquinazolinium iodide. 2-ethyl-4-methyl-mercapto-l-(4-methyl-phenyl)- quinazolinium iodide. 2-benzyl-4-methylmercapto-1-(3-trifiuorometl1yl phenyD-quinazolinium iodide.

4-ethylmercapto-l,2-diphenyl-dmethoxyquinazolinium iodide.

1,Z-diphenyl-dmethyl-4-methyl-mercaptoquinazolinium iodide.

o-ehloro-l,2-dipheny1-4-methyl-niercaptoquinazolinium iodide.

1-(3,4-dichloro-phenyl)-4-methyl-mercapto-244- methyl-phenyl)-quinazolinium iodide.

4-benzylmercapto-l-(4-bron1o-pheny1)-2- isopropyl-quinazolinium iodide.

4(methyhnercapto-2-(3-nitrophenyl) -l-phenylquinazolinium iodide. 2-(4-bromo-phenyl)-4-methylmercapto-l-phenylquinazoli iium iodide. A-methylmcrcapto-2-(4-rnethyl-pheny1) 1-pheny1- quiiiazolinium iodide. 2-(4-methoxy-phenyl)-4-methylmercapto-1-(2- naphthyD-quinazolinium iodide.

4etliylmercapto-2-(4-methylmercnpto-phenyl) -1- phenyl-quinazolinium iodide.

2-methyl--methyl-mereapto-1-pheny1-quinazolinium iodide.

Example 8 Through the deep red solution of 0.7 g. of 1-(4-fluoro- Azaheterocyclie aryl quaternary compounds 4-aznarylidenemethylquinazolinium product 2-inethylbenzothiazole methiodide 1,Z-diphenyl-4-(ii-methyl-Z-benzothiazolylidene- 4 methyl) -quinozoliniuni iodide. 2-quinaldine iodide 1,2-diphenyl4-(l-ethyl-2-quinolylidene-methyl)- quinazolinium iodide. fi-N ,N-diethylamino-2-quina1dine methiodide- 4-(G-N,N-diethylamino-1-methyl-2-quinolylidenemethyl)-1,2-diphenylquinazolinium iodide. Z-methyl-oxazole mcthiodide- 4-(3-methyl-2-oxazolylidene-methyl)-2-(3-nitrophenyl) -l-pheny1-quinazolinium iodide. 2,3,3-trimethyl-indolenine methiodide 2-(4-bromo-phenyl) -l-pheny1A-(1,3,3-trimethyl- 2-indo1ylidene-methy1)-quinazo1iiiium iodide. Z-quinaldine ethiodide 4-(l-ethyl-Z-quinolylidinc-methyl)-2-(4-methy1- phenyl)-l-phenyl-quinazolinium iodide. 2methyl-benzothiazole methiodide 2-(4-Inethoxy-phenyl)-4-(3methyl-2-benzothiazolylidene-methyl)-1-(2-naphthyl)-quinazolinium iodide.

Z-quinaldine methiodide 2-(4-mcthylmercapto-phenyl)-4-(1-methyl-2- quinolylidenemethyl)-1-phenyl-quinazolinium iodide.

Z-quinaldine ethiodide 4-(l-ethyl-Z-quinolylidenemethyl) -2-methy1-1- phenyl-quinazolinium iodide.

Example 9 35 The mixture of 0.25 g. of 1-(4-fiuoro-phenyl)-4-methphenyl)-4-methylmercapto 2 phenyl-quinazolinium i dide in ml. of dimethylformamide, methylamine is bubbled until the color changes to pale yellow. After standing at room temperature for 15 minutes water is added until no more precipitate is formed. The latter is filtered off and recrystallized once from diethyl ether to yield the 1-(4-fluoro-phenyl)-4-methylimino-2phenyl-1,4-dihydro-quinazoline of the formula ILL-CH3 melting at 228230.

By using ammonia, ethylainine or dimethylamine instead of methylamine the l-( 4-fluoro-phenyl)-4-irnino2- p'henyl-l,4-dihydro-quinazoline, 1-(4 fluoro-phenyl)-4- ethylimino-Z-phenyl-1,4-dihydro-quinazoline and 1 (4- fluoropheny1)-4-dimethylamino-2-phenyl quinazolinium iodide of the formula are obtained.

ylmercapto-Z-phenyl-quinazolinium iodide and 1.0 ml. of Z-dimethylamino-ethylamine is allowed to stand at room temperature until the orange color disappears and the gas evolution ceases. After about 10 minutes water is added, the precipitate formed is filtered off and recrystallized once from diethyl ether-pentane with the use of charcoal. There is obtained the 1-(4-fiuoro-phenyD-4-(2- dimethylamino-ethylimino)-2-pheny1-1,4 dihydro-quinazoline of the formula melting at 181483 In the analogous manner the 1-(4-fluoro-pheny1)-4- (2methylamino-ethylimino)-2 phenyl-1,4-dihydr0-quinazoline and the 1-(4-fluoro-phenyl)-4-(2-amino-ethylimino)-Z-phenyl-1,4-dihydroquinazoline are prepared.

Example 10 0.5 g. of 1-(4-fluoro-phenyl) 4 methylmercapto-Z- phenyl-quinazolinium iodide and 1.5 .g. of N-(Z-aminoethyl)-N'-phenyl-piperazine are mixed together and the mixture is molten on a steam bath, during which methylmercaptan is given off and the orange color disappears. After about 15 minutes water is added and the white solid filtered off. It is recrystallized once from acetone and yields the 1-(4-fluoro-phenyl)-4-[2-(4-phenyl-piperazino).-ethylimino]-2-phenyl-1,4-dihydro quinazoline of the formula U I C) NCH2CH2N NQ mleting at 244-246 with decomposition.

Using glycine or its rnethylester, instead of the piperazine compound, the 1-(4 fiuoro-phenyl)-4-(carboxymethylimino)-2-phenyl-1,4-dihydro quinazoline of the formula I N--CHr-COOH or its methylester can be prepared.

Example 11 Ammonia is bubbled through the dark red solution of 2.2 g. of 1-(4-fluoro-phenyl)-2-pheny1-4-methylmercapto-quinazolinium iodide in 40 ml. of dimethylformamide, causing a rapid color change to pale yellow. Bubbling is continued for another minutes, then the mixture is allowed to stand for minutes. It is filtered through sintered glass to remove a trace of insoluble matter, then water is added to the filtrate causing a pale yellow-white solid to precipitate. This is filtered 01f, airdried and recrystallized 3 times from acetone-diethyl ether to yield the 1-(4-fiuoro-phenyl)-4-imino-2-phenyl- 1,4-dihydro-quinazoline of the formula.

I NH

melting at 243-245 Example 12 Monoethylamine is bubbled through the dark red solution of 1.5 g. of 1-(4-fluoro-phenyl)-2-phenyl-4-methy1- mercapto-quinazolinium iodide in 30 ml. of dimethyl formamide, causing a rapid color change to pale yellow. Bubbling is continued for 5 minutes, then the solution is allowed to stand for 15 minutes. Water is added until no more precipitate appears. The white solid precipitate is filtered off and recrystallized from acetonediethyl 16 ether to yield the 1-(4-fiuoro-phenyl)-4-ethylimino-2- phenyl-1,4-dihydroquinazoline of the formula I I-CH:-CH3CH3 melting at 234235.

Example 14 In the analogous manner described in the previous example the following compounds can be prepared using the equivalent amount of the corresponding starting matennis:

Compound M.P., Recrystallized deg. [rom- 4-i-propylin1inu-l-(4-fiu0ro-phenyl)-2-phonyl- 217-219 Diethyl ether.

1,4-dihydro-quinazoline. 4-n-butylin1ino-1-(4-tluoro-phenyl)-2-phenyl- 195-197 Acetone.

1,4-dihydro-quinazoline. 4-(2-butyl)-imino-1-(4-iluorophenyl)-2- 190-198 Methanol.

phenyl-l,4'dihydroqninazoline. 4-(Z-methyl-propyl)-imino-1-(4-fluor0- 204-213 Do.

phenyl)-2-phenyl1,4-dihydro-quinoliue. 4-n-pentylirnino-l-(4-fiuoro-phenyl)-2- 182-184 Acetone.

phenyl-I,4-dihydro-quinazoline.

Example 15 0.5 g. 1 (4-fluoro-phenyl)-2-phenyl-4-n-propylimino- 1,4,5,6,7,8-hexahydro-quinazoline are dissolved in ml. cyclohexane, to the solution 0.1 g. 10% palladium-charcoal are added and the mixture is refluxed for 24 hours. Hereupon the catalyst is filtered off, the filtrate evaporated under reduced pressure and the residue recrystallized from acetone using charcoal for decolorization to yield the l- (4 fiuoro phenyl) 4 n-propylimino-Z-phenyl-1,4- dihydro-quinazoline which is identical with that obtained according to Example 13.

Example 16 0.5 g. of 1 (4 fiuoro phenyl) 2-phenyl-4-n-propylirnino 1,4,5,6,7,8 hexahydro-quinazoline and 0.2 g. sulfur are dissolved in the minimum amount of dimethylformamide necessary for dissolution, the whole is refiuxed for 30 minutes, then the mixture is evaporated under reduced pressure, the residue is dissolved in acetone, the solution filtered, the filtrate concentrated and kept in the cool to yield the crystalline 1 (4 fluorophenyl) 4 n propylimino 2 phenyl-1,4-dihydroquinazoline which is identical with that obtained according to Example 13.

What is claimed is:

1. A member selected from the group consisting of the compound having the formula c-R. A111 Pllg I in which Ph stands for a member selected from the group consisting of 1,2-phenylene, (lower alkyl) 1,2- phenylene, (lower alkoxy) 1,2 phenylene, (halogeno)- 1,2 phenylene, (lower alkylmercapto) 1,2 phenylene and (nitro) 1,2 phenylene, R for a member selected from the group consisting of phenyl, (lower alkyl)-pheny1 (lower alkoxy) phenyl, (halogeno) phenyl, (lower alkylmercapto) phenyl and (nitro) phenyl, R for a member selected from the group consisting of lower alkyl, phenyl, (lower alkyl) phenyl, (lower alkoxy) phenyl, (halogeno) phenyl, (lower alkylmercapto)-phenyl and (nitro) phenyl, R for lower alkylmercapto, and A11 for a halogenide ion.

2. A compound as claimed in claim 1, in which formula Ph stands for 1,2 phenylene, R for a member selected from the group consisting of phenyl, (lower alkyl) phenyl, (lower alkoxy) phenyl and (halogen0)- phenyl, R for a member selected from the group consisting of lower alkyl, phenyl, (lower alkyl) phenyl, (lower alkoxy) phenyl and (halogeno) phenyl, R for lower alkylmercapto, and An for a halogenide ion.

3. 1 (4 fluoro phenyl) 4 methylmercapto-Z- phenyl-quinazolinium iodide.

4. 1,2 diphenyl 4 methylmercapto-quinazoliniurn iodide.

5. 1 phenyl 2 methyl 4 methylmercapto-quinazolinium iodide.

6. 1 (4 methoxy phenyl) 4-methylmercapto-2- phenyl-quinazolinium iodide.

References Cited UNITED STATES PATENTS 2,495,260 1/1950 Jennen et a1. 260-240.6 2,715,623 8/1955 Fry et al. 260240.6 2,895,957 7/1959 Jeffreys et al 260-2406 OTHER REFERENCES Fry et al.: J. Chem. Soc. 1960, 5062-5072.

Carney et 211.: J. Org. Chem., vol. 29, pp. 2887-2889 (October 1964).

Huang-Hsinmin et al.: J. Chem. Soc. 1949 pp. 2905- 2906 and 2911.

De Stevens et al.: Amer. Chem. Soc. Absts. of Papers, th meeting, pp. 59Q60Q (Aug. 27, 1963).

JOHN D. RANDOLPH, Primal Examiner. 

